Related references
Note: Only part of the references are listed.The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Anastasios G. Konstas et al.
EXPERT OPINION ON DRUG SAFETY (2021)
Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops
Daisuke Inoue et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2020)
The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Marta Misiuk-Hojlo et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2019)
Patient-Reported Nonadherence with Glaucoma Therapy
Christian Wolfram et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Review and analysis of grading scales for ocular surface staining
Carolyn Begley et al.
OCULAR SURFACE (2019)
Eye Drop Dispenser Type and Medication Possession Ratio in Patients With Glaucoma: Single-Use Containers Versus Multiple-Use Bottles
Kun-Hoo Na et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
Treatment patterns and medication adherence of patients with glaucoma in South Korea
Chan Yun Kim et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2017)
Evaluating Corneal Fluorescein Staining Using a Novel Automated Method
Francisco Amparo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 A Systematic Review and Meta-Analysis
Yih-Chung Tham et al.
OPHTHALMOLOGY (2014)
Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma
Jean-Francois Rouland et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients
Gemma Caterina Maria Rossi et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2013)
Ocular Surface Disease and Glaucoma: How to Evaluate Impact on Quality of Life
Gemma Caterina Maria Rossi et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
The Impact of Ocular Adverse Effects in Patients Treated With Topical Prostaglandin Analogs: Changes in Prescription Patterns and Patient Persistence
Thom J. Zimmerman et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Corneal Penetration into Rabbit Aqueous Humor Is Comparable between Preserved and Preservative-Free Tafluprost
Pertti Pellinen et al.
OPHTHALMIC RESEARCH (2009)
Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma
Christophe Baudouin
ACTA OPHTHALMOLOGICA (2008)
Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea
Soumyajit Majumdar et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Duration of IOP reduction with travoprost BAK-free solution
Ronald L. Gross et al.
JOURNAL OF GLAUCOMA (2008)
Effect of benzalkonium chloride on transscleral drug delivery
K Okabe et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Grading of corneal and conjunctival staining in the context of other dry eye tests
AJ Bron et al.
CORNEA (2003)
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
PJ Pisella et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Proof of efficacy trials: cross-over versus parallel-group
A Richens
EPILEPSY RESEARCH (2001)
Share Paper
